Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Trimuda Nuansa Citra Tbk. (TNCA) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Trimuda Nuansa Citra Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Trimuda Nuansa Citra Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp163 (market cap 69.99B, 6.77M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 4.5× Trimuda Nuansa Citra Tbk.'s market cap, and Trimuda Nuansa Citra Tbk. is more actively traded (6.77M versus 41.7K). Which is the better fit depends on your goals.

DGNSTNCA
Market Cap
316.25B69.99B
Volume
41.7K6.77M
Lot
41767.74K
Turnover
9.66M1.17B
Average Price
231.65173.21
Value
9.66M1.17B
Indicative Equilibrium Price
230163
Indicative Equilibrium Volume
2.4K327

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
TNCA
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Trimuda Nuansa Citra Tbk.

PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.

Read more on TNCA